The Integrated Mathematical Oncology department uses the integration of theory & experiments to better understand cancer initiation, progression & treatment.
Live from #AACR26: I spoke with Sandy Anderson, PhD (@ara_anderson), about math oncology and how it’s helping us better predict cancer outcomes.
By using data and machine learning, researchers can model how cancer may grow and respond to treatment, bringing us closer to more informed, personalized care.
#AACR26 #MoffittAACR26 @MoffittNews
Ok I know at this point it might be a waste of time but I'm determined to finish posting about #MathOnco25! We were about half way through day 3 but before I go on there it wasn't all work - we also had lots of fun!
Next is #AndersonLab member M A Masud @masud_math: "Developing model-based pipeline for combination therapy cycling: KRAS mutated NSCLC". Unfortunately the recording didn't work for Masuds presentation but expect a preprint on this work shortly @mathonco#MathOnco25@MoffittNews
Behind the paper: Mathematical modelling predicts selective sweeps are restricted to early stages of tumour growth
https://t.co/9U1kIB6pWI
by @alexstein_#cancer#evolution#mathonco
In 2026, please consider following the journey of math oncology research by subscribing to our newsletter (7yrs, 350 issues, 2500 subs):
https://t.co/RaB4tQViSH
Tomorrow's newsletter is a recap of 2025, and links to papers on fitness landscapes, cancer evolution, virtual trials, and more...
This book chapter outlines possible ideas for "Evolution-based treatment protocols".
Ch 38, in "Cancer Systems Biology: Translational Mathematical Oncology"
https://t.co/FoVdEhQ4ZB
Only a few more days before the deadline: December 1st!
Unique fully-funded PhD program in #MathOnco (and other disciplines) in an National Cancer Institute (@theNCI) designated cancer center
Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025
Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors:
• Cancer Biology
• Cancer Chemical Biology
• Cancer Immunology & Immunotherapy
• Integrated Mathematical Oncology
Why Moffitt?
• Access to top research facilities
• Collaborate with world-leading scientists
• Hands-on experience in cutting-edge research
• Supportive environment for innovation
• Unmatched translational environment, turning discoveries into cures
Start your journey to make a difference in cancer care and innovation.
Learn more and apply now: https://t.co/qc33S8WvUe
🎓 Congratulations to Malgorzata (Gosia) Weh, PhD on the successful defense of her doctoral dissertation entitled, “The Only Constant is Change: the Role of Genetic Diversification in Cancer and Beyond”. Gosia was mentored by David Basanta and @AndriyMarusyk during her PhD.👏🏼👏🏼👏🏼
It’s that time of the year again! Welcome to the 13th IMO Workshop @mathonco which has begun in full swing! Looking forward to the next 5 days of team science! @MoffittNews
Day 1: Say hi to #TeamBlue! Preliminary brainstorming and discussions on-going to come up with our research question by 4pm!
Cheers to our team leads: @ReneeBradyPhD, Jorge Mansilla-Soto,PhD and Nicholas Champion, MD
@mathonco@MoffittNews
It’s day 3 of #MathOnco25 and we have a whole day of talks on @EvolTherapy all funded through a generous donation from the Jacobson Foundation! If you are not attending in person you can follow along online: https://t.co/LptdTFle9Q @MoffittNews
Opening the afternoon session is former student, friend, collaborator and radiotherapy innovator from @MDAndersonNews Heiko Enderling Didactic: Heiko Enderling: "Radiation radiobiology unleashed: Cross-disciplinary modeling breakthroughs”
Closing the morning session of day 2 is @Novartis postdoc Paul Schwerd-Kleine: "Modeling tumor drug responses across cells, mice, and patients" #MathOnco25
Next Khola Jamshad: "Modeling Cancer Evolution: A Data-Driven Agent-Based Modeling Approach to Intratumor Heterogeneity and Drug Resistance in Melanoma" #MathOnco25